Clinical Trials Browser

Phase 3 × OTHER × Hand-Foot Syndrome × Clear all

NCT05165069 2026-02-02

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Phase 3 Active not recruiting

Breast Neoplasms, Hand-Foot Syndrome

NCT05327751 2022-04-14

HFS

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT02794493 2019-07-25

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

Phase 3 Completed

Hand-Foot Syndrome

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Phase 3 Terminated

Hand-Foot Syndrome